Health

Perhaps, if the Sharri Briley and Eric Edmundson Veterans Benefits Expansion Act becomes law. The bill just recently passed the House of Representatives. Newsweek summarizes the bill’s provisions as follows: The bill would increase Dependency and Indemnity Compensation benefits by 1.5 percent over two years. Those payments are provided by the Department of Veterans Affairs (VA) to…

Ebola outbreak in the Congo. AI Mathematicians. Why Long-Term Care Policy Keeps Failing. ISPOR: first, second and third plenary. The Indiana Bears?

The answer is provided by EFPIA’s annual WAIT indicator (press release, report). First, we see a large decrease in the share of pharmaceuticals fully availbity, drive by a small increase in reduced availability but a much larger increase in the number of drugs that only have a limited availability. Specifically, Historically full availability was the…

At least, it won’t be overturned by the US Supreme Court. Endpoints reports: The Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare drug price negotiations. The justices declined to review multiple cases brought by AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Novo Nordisk, Novartis and Boehringer Ingelheim… The…

If you are a payer or a policymaker, should you except the results of a global clinical trial or require additional evidence that a drug works in your country.  There are a few options to consider. Delay approval until local confirmatory trial.  Approach enacted in several Asian countries (see Habr et al. 2024).  While this…